A major focus of our lab is engineering innovation for analysis of complex biological systems -- as is required to address questions important to both fundamental biological systems and applied clinical research. We employ a combination of approaches drawn from chemical engineering, mechanical engineering, and electrical engineering with strong foundations in biology, materials science, and analytical chemistry. In essence, we strive to advance the "mathematization" of biology & medicine. Our research projects span understanding fundamental transport to materials design to applications in life sciences tools and diagnostics.
In the News
Introducing this year’s top innovators under 35, a list compiled each year by MIT Technology Review.
Four UC Berkeley engineering professors took part in the World Economic Forum’s ninth Annual Meeting of the New Champions, a global conference on innovation, science and technology held last week in Dalian, China. Ab
Lab tests that detect prostate cancer can’t reveal if the cancer poses a real risk. It looks for elevated levels of a protein called PSA, but about 80 percent of cancers that generate high PSA levels grow so slowly and may never need treatment. New research by Amy Herr points the way to a much more refined assessment of proteins and the promise of better diagnosis and treatment of a range of diseases.
In its first year, the initiative will give research innovations by six early-career UC Berkeley faculty members — including technologies to move prosthetic limbs with the power of thought and to control Argentine ants using their own pheromones — a significant boost from the lab to the market.
Three UC Berkeley faculty members - Diana Bautista, Amy Herr and Donald Rio - have been singled out as innovators by the National Institutes of Health and will receive special grants designed to fund "transformative research" that could lead to major advances in medical science.